Screener
Haemonetics HAE Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
FAQ
- What is Haemonetics's long-term debt?
- Haemonetics (HAE) reported long-term debt of $1.17B in Q2 2026.
- How has Haemonetics's long-term debt changed year-over-year?
- Haemonetics's long-term debt increased by 27.0% year-over-year, from $920.83M to $1.17B.
- What is the long-term trend for Haemonetics's long-term debt?
- Over 5 years (2021 to 2026), Haemonetics's long-term debt has grown at a 12.0% compound annual growth rate (CAGR), from $690.59M to $1.22B.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.
Ask your AI about Haemonetics's long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude